See you in San Diego!

Members of the T2D Knowledge Portal team are gearing up for the 77th Scientific Sessions of the American Diabetes Association, June 9-13 in San Diego, CA. We'll be releasing exciting new features of the Portal just before the conference, and we have a wide variety of presentations planned for each day.

On the opening day of the conference (Friday, June 9), join us for a mini-symposium that will present a comprehensive guide to the T2D Knowledge Portal and how you can use it to further your type 2 diabetes research. We will be exhibiting at booth #2452 on Saturday, Sunday, and Monday, and each day, genetics experts will be available at the booth to answer questions and discuss both the Portal and the genetics of T2D. On Saturday, members of the Portal team will participate in a moderated poster session, and posters will also be displayed on Monday. And on Sunday morning, our principal investigator, Dr. Jose C. Florez, will give a symposium presentation on "Mining the Genome for Therapeutic Targets."

Find the full details in the schedule below and follow us on Twitter (@T2DKP) for up-to-the-minute news throughout the conference. We're looking forward to meeting you!

Friday, June 9, 2017

Mini-Symposium: A Researcher’s Guide to Exploring Diabetes Genetic Data in the Type 2 Diabetes Knowledge Portal
Chair: Mark McCarthy
11:30am - 12:30pm, Room 28

11:30-11:50am        Noël Burtt: Data, Analysis, and Tools in the Type 2 Diabetes Knowledge Portal
11:50am-12:10pm   Jason Flannick: Demonstration of Questions that Can Be Addressed Using the Portal

12:10-12:30pm       Question and Discussion Period


Saturday, June 10, 2017

• Exhibiting at booth #2452, 10am - 4pm

• Moderated Poster Session: Genetic Data, Pathways, and Variants for Type 2 Diabetes and Related Traits. 12:30-1:30pm, Hall B

Poster 1765-P
The Type 2 Diabetes Knowledge Portal: Accelerating Type 2 Diabetes Research through Community Access to Human Genetic Information and Tools
Presenter: Maria C. Costanzo

Poster 1766-P
Key Biological Pathways for Type 2 Diabetes Determined by Genetic Cluster Analysis on Related Traits
Presenter: Miriam S. Udler

Sunday, June 11, 2017

• Symposium presentation: Mining the Genome for Therapeutic Targets. 

Dr. Jose C. Florez

9:20-9:55am, Ballroom 20D

• Exhibiting at booth #2452, 10am - 4pm

Monday, June 12, 2017

• Exhibiting at booth #2452, 10am - 2pm

• Poster session, 12-1pm, Hall B

Poster 1765-P

The Type 2 Diabetes Knowledge Portal: Accelerating Type 2 Diabetes Research through Community Access to Human Genetic Information and Tools
Presenter: Maria C. Costanzo

Poster 1795-P
Type 2 Diabetes Gene Bioinformatically Identified by Variants Mapping to Amino-Acid Changes in Three-Dimensional Protein Space
Presenter: Marcin von Grotthuss

Explore new datasets and phenotypes in the T2D Knowledge Portal

We are releasing multiple new datasets in the Portal and have updated existing sets with associations for new phenotypes. To make it even easier to browse and explore these sets, we've also updated our Data page and added new functionality. Here's an overview of what's new in the Portal today.

17K exome sequence analysis dataset has grown to 19K
The Data Coordinating Center (DCC) of the Accelerating Medicines Partnership in Type 2 Diabetes (AMP T2D) analyzes exome sequence data contributed by AMP T2D consortium members to find variant associations with T2D and related traits. The exome sequencing dataset available in the Portal has until now consisted of exome sequences from about 17,000 individuals. Today, we have added exome sequencing performed on 2,000 Danish subjects by the LuCamp (Lubeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care) consortium, making a total of nearly 19,000 exomes. This is just a taste of things to come: at the AMP T2D DCC we are currently analyzing additional exome sequences that will bring the total up to 52,000!

New community-contributed datasets: GENESIS GWAS and 70KforT2D GWAS
We are grateful to two groups from the larger T2D research community who have shared data that will make the T2D Knowledge Portal even more valuable to worldwide T2D researchers.

The GENEticS of Insulin Sensitivity (GENESIS) consortium performed GWAS on over 2,700 nondiabetic participants, finding genetic associations with direct measures of insulin sensitivity.

The 70KforT2D project collected, harmonized, and re-analyzed public GWAS data from over 70,000 individuals to find T2D genetic associations.

New public dataset: VATGen GWAS
The VATGen GWAS consortium performed meta-analysis of GWAS data from a mixed-ancestry group of more than 18,000 people to identify genetic associations with the localization of body fat deposition, leading to insights into adipocyte development.

Updated dataset: glucose-stimulated insulin secretion phenotypes in MAGIC GWAS
A study by Prokopenko et al. analyzed genetic associations with insulin secretion. Associations of variants with nine different measures of insulin secretion, among them corrected insulin response (CIR) and disposition index (DI), have now been added to the MAGIC GWAS dataset.

ExAC updated to gnomAD exomes and whole genomes
The Exome Aggregation Consortium (ExAC) has more than doubled in size and has morphed into the Genome Aggregation Database (gnomAD). More than 120,000 exome sequences and 15,000 whole genome sequences are now available, and these data are accessible via several tools and interfaces in the T2D Knowledge Portal.

New Data page: explore datasets using new filters
As our collection of data grows, it becomes more difficult to understand the differences between datasets and to find those of interest. To address this challenge, we've reorganized and streamlined our Data page.

A section of the Data page, expanded to show phenotype selection.

At the top of the Data page, you can choose to filter the dataset table by data type, phenotype category, or both. When you click on a phenotype category, the phenotypes within that category are available for selection. Clicking on the name of any dataset expands a section with details and references for each. 

In the coming days, watch this space for more details about each of these new developments. And as always, please contact us if you have any comments or questions.